|
|
Britannia Life Sciences Inc
CSE •
Healthcare •
Biotechnology •
Quote as of 06/12/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeCSE
Market Capitalization14.6 mln
Earnings Date08/27/2025
P / E
1.33
Deeply undervalued
Key Fundamentals
EPS0.06
P/E1.33
ROE290
RPS0.00
ROIC-17.22
ROA135
EBITDA, mln9.56
EV / EBITDA-0.11
EV / EBIT-0.11
Revenue, mln0.57
EV / Revenue-1.82
Financial Strength
Altman Z-Score3.78
Piotroski F-Score
6
/ 9
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
0% |
65
/ 100
 |
| 1 Month |
-5.56% |
62
/ 100
 |
| 2 Months |
-10.53% |
59
/ 100
 |
| 6 Months |
-19.05% |
45
/ 100
 |
| 1 Year |
70% |
78
/ 100
 |
|
| |
